GCM
CBAY

Graham Capital Management’s Cymabay Therapeutics CBAY Stock Holding History

Graham Capital Management’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-68,579
Closed -$751K – 1343
2023
Q2 		$751K Sell
68,579
-76,395
-53% -$837K 0.02% 429
2023
Q1 		$1.26M Buy
144,974
+117,896
+435% +$1.03M 0.04% 412
2022
Q4 		$170K Buy
+27,078
New +$170K 0.01% 969